Menu
Find People
Find Everything
About This Site
Edit My Profile
Login to Profiles
DIRECT2Experts
Help / FAQ
History
Telehealth Utilization
Agranulocytosis
FOXO3a loss is a frequ
Relationship between C
Synergistic induction
See All (10) pages
Keywords
Last Name
Institution
@uada.edu
@ualr.edu
@uapb.edu
@uark.edu
University of Arkansas for Medical Sciences
More Search Options
Announcement
You can now add alternative names!
Click here
to add other names that you've published under.
Synergistic induction of apoptosis in high-risk DLBCL by BCL2 inhibition with ABT-199 combined with pharmacologic loss of MCL1.
Li L, Pongtornpipat P, Tiutan T, Kendrick SL, Park S, Persky DO, Rimsza LM, Puvvada SD, Schatz JH. Synergistic induction of apoptosis in high-risk DLBCL by BCL2 inhibition with ABT-199 combined with pharmacologic loss of MCL1. Leukemia. 2015 Aug; 29(8):1702-12.
View in:
PubMed
subject areas
Animals
Antineoplastic Combined Chemotherapy Protocols
Apoptosis
Cell Proliferation
Cyclic N-Oxides
Drug Synergism
Female
Humans
Immunoenzyme Techniques
Indolizines
Lymphoma, Large B-Cell, Diffuse
Mice
Mice, Inbred NOD
Mice, SCID
Proto-Oncogene Proteins c-bcl-2
Pyridinium Compounds
Real-Time Polymerase Chain Reaction
Reverse Transcriptase Polymerase Chain Reaction
RNA, Messenger
Sulfonamides
Tissue Array Analysis
Tumor Cells, Cultured
Xenograft Model Antitumor Assays
authors with profiles
Samantha Kendrick